Citation: P. Mohr et al., COMBINED TREATMENT OF STAGE-IV MELANOMA PATIENTS WITH AMIFOSTINE AND FOTEMUSTINE - A PILOT-STUDY, Melanoma research, 8(2), 1998, pp. 166-169
Authors:
SCHADENDORF D
SUN Y
MOLLER H
MAKKI A
DORBIC T
WITTIG B
HENZ BM
MOLLER P
Citation: D. Schadendorf et al., IL-7-GENE-TRANSFER INTO AUTOLOGOUS MELANOMA-CELLS FOR VACCINATION - APILOT-STUDY IN PATIENTS WITH ADVANCED MELANOMA, Journal of investigative dermatology, 107(3), 1996, pp. 40-40
Authors:
KERN MA
ARTUC M
HELMBACH H
KARMANN D
MAKKI A
SCHADENDORF D
Citation: Ma. Kern et al., ANALYSIS OF DRUG-RESISTANCE OF MELANOMA-CELLS - PHARMACOLOGICAL CHARACTERIZATION, CROSS-RESISTANCE AND GENETIC-REGULATION, Journal of investigative dermatology, 107(3), 1996, pp. 43-43
Authors:
SCHADENDORF D
KERN MA
ARTUC M
PAHL HL
ROSENBACH T
FICHTNER I
NURNBERG W
STUTING S
VONSTEBUT E
WORM M
MAKKI A
JURGOVSKY K
KOLDE G
HENZ BM
Citation: D. Schadendorf et al., TREATMENT OF MELANOMA-CELLS WITH THE SYNTHETIC RETINOID CD437 INDUCESAPOPTOSIS VIA ACTIVATION OF AP-1 IN-VITRO, AND CAUSES GROWTH-INHIBITION IN XENOGRAFTS IN-VIVO, The Journal of cell biology, 135(6), 1996, pp. 1889-1898
Authors:
SCHADENDORF D
FICHTNER I
MAKKI A
ALIJAGIC S
KUPPER M
MROWIETZ U
HENZ BM
Citation: D. Schadendorf et al., METASTATIC POTENTIAL OF HUMAN-MELANOMA CELLS IN NUDE-MICE - CHARACTERIZATION OF PHENOTYPE, CYTOKINE SECRETION AND TUMOR-ASSOCIATED ANTIGENS, British Journal of Cancer, 74(2), 1996, pp. 194-199
Authors:
SCHADENDORF D
MAKKI A
STAHR C
VANDYCK A
WANNER R
SCHEFFER GL
FLENS MJ
SCHEPER R
HENZ BM
Citation: D. Schadendorf et al., MEMBRANE-TRANSPORT PROTEINS ASSOCIATED WITH DRUG-RESISTANCE EXPRESSEDIN HUMAN-MELANOMA, The American journal of pathology, 147(6), 1995, pp. 1545-1552